Back
#1
14.8%
Top 5%
12.0%
Top 0.9%
9.1%
Top 19%
7.9%
Top 71%
6.5%
#1
6.0%
Top 3%
5.1%
Top 7%
5.1%
Top 3%
5.1%
Top 6%
4.2%
Top 8%
1.6%
Top 42%
1.6%
Top 0.4%
1.4%
Top 10%
1.4%
Top 4%
1.2%
Top 12%
1.2%
Top 92%
1.0%
Top 6%
1.0%
Top 45%
1.0%
Top 11%
1.0%
Top 26%
1.0%
Top 30%
0.7%
Bacillus Calmette-Guerin (BCG) vaccination: a global analysis of cost-effectiveness and optimal safety stock
2025-12-15
health economics
Title + abstract only
View on medRxiv
Show abstract
BackgroundBacille Calmette-Guerin (BCG) is the most commonly-used vaccination globally, but multi-country cost-effectiveness analyses are outdated and have not considered sequelae in tuberculosis survivors. A rationale is lacking to guide the size of safety stocks. MethodsFor the 110 countries using universal neonatal BCG vaccination, we used a decision tree model to compare the costs and health benefits of status-quo BCG vaccination for children aged 0-4 years in 2023 to a counterfactual where...
Predicted journal destinations
1
PLOS Medicine
95 training papers
2
PLOS Global Public Health
287 training papers
3
BMJ Global Health
95 training papers
4
BMJ Open
553 training papers
5
PLOS ONE
1737 training papers
6
eClinicalMedicine
55 training papers
7
BMC Medicine
155 training papers
8
Clinical Infectious Diseases
219 training papers
9
Vaccine
140 training papers
10
PLOS Neglected Tropical Diseases
166 training papers
11
Proceedings of the National Academy of Sciences
100 training papers
12
Nature Communications
483 training papers
13
The Lancet Global Health
24 training papers
14
Open Forum Infectious Diseases
124 training papers
15
BMC Health Services Research
43 training papers
16
The Journal of Infectious Diseases
137 training papers
17
Scientific Reports
701 training papers
18
The Lancet Infectious Diseases
57 training papers
19
eLife
262 training papers
20
Vaccines
131 training papers
21
BMC Public Health
148 training papers
22
JAMA Network Open
125 training papers